Immunodiagnostic Systems Holdings plc announced that two SARS-CoV-2 Antigen Rapid Test kits are available for sale in the UK, European Union and other countries which accept the CE mark as the basis of regulatory approval. Both tests can be performed by a trained healthcare professional in community locations (e.g. workplaces, schools, doctors' surgeries) without the need for any laboratory equipment.  These tests determine the presence of the SARS-CoV-2 nucleocapsid protein antigen using direct nasopharyngeal swab samples, providing a result within 15 minutes. Both fast and easy to use tests are based on the lateral flow principle: one in a cassette format, one in a test card format.  These tests are provided by partners of IDS and have been assessed by the manufacturers as having the following performance characteristics: Lateral Flow cassette specificity 99.2%, sensitivity 96.7% and time to result 15 minutes. Lateral Flow card specificity 99.3%, sensitivity 92.0% and time to results 15 minutes. IDS offers a comprehensive portfolio of SARS-CoV-2 antigen and antibody tests for the laboratory as well as for community locations.